ArticleJournal of clinical medicine2024

Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1.

Hiroto Takada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.